Laboratory of Veterinary Biochemistry and Molecular Biology, Veterinary Medical Center and College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Korea.
Int J Environ Res Public Health. 2018 Jul 30;15(8):1614. doi: 10.3390/ijerph15081614.
Miscarriage due to blastocyst implantation failure occurs in up to two-thirds of all human miscarriage cases. Calcium ion has been shown to be involved in many cellular signal transduction pathways as well as in the regulation of cell adhesion, which is necessary for the embryo implantation process. Exposure to endocrine-disrupting chemicals (EDs) during early gestation results in disruption of intrauterine implantation and uterine reception, leading to implantation failure. In this study, ovarian estrogen (E2), bisphenol A (BPA), or 4--octylphenol (OP), with or without ICI 182,780 (ICI) were injected subcutaneously from gestation day 1 to gestation day 3 post-coitus. The expression levels of the calcium transport genes were assessed in maternal uteri and implantation sites. The number of implantation sites was significantly low in the OP group, and implantation sites were absent in the E2, ICI and EDs + ICI groups. There were different calcium transient transport channel expression levels in uterus and implantation site samples. The levels of and gene expression were significantly increased by EDs with/without ICI treatment in utero. Meanwhile, TRPV5 and TRPV6 gene expression were significantly lower in implantation sites samples. and mRNA levels were significantly decreased by OP and BPA in the implantation site samples. Compared to vehicle treatment in the uterus, both the MUC1 mRNA and protein levels were markedly high in all but the BPA group. Taken together, these results suggest that both BPA and OP can impair embryo implantation through alteration of calcium transport gene expressions and by affecting uterine receptivity.
由于胚胎着床失败导致的流产在所有人类流产病例中占比高达三分之二。钙离子已被证明参与了许多细胞信号转导途径以及细胞黏附的调节,而后者是胚胎着床过程所必需的。胚胎早期暴露于内分泌干扰化学物质(EDCs)会破坏子宫内着床和子宫接受能力,从而导致着床失败。在这项研究中,从妊娠第 1 天到妊娠第 3 天,通过皮下注射卵巢雌激素(E2)、双酚 A(BPA)或 4-辛基酚(OP),并伴有或不伴有 ICI 182,780(ICI)。在母体子宫和着床部位评估钙转运基因的表达水平。OP 组着床部位数量明显减少,E2、ICI 和 EDCs+ICI 组无着床部位。子宫和着床部位样本中的钙瞬变转运通道表达水平存在差异。EDCs 处理会导致 和 基因表达在子宫内显著增加,而 ICI 处理则无此效果。同时,TRPV5 和 TRPV6 基因在着床部位样本中的表达显著降低。OP 和 BPA 处理会导致着床部位样本中 TRPV5 和 TRPV6 基因表达显著降低。与子宫内的载体处理相比,除 BPA 组外,所有组的 MUC1 mRNA 和蛋白水平均显著升高。综上所述,这些结果表明,BPA 和 OP 均可通过改变钙转运基因的表达以及影响子宫接受能力来损害胚胎着床。